Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 49.20%.However, over the last six months, we can see a stronger performance of -69.91%. Over the last 30 days, the price of ELEV has fallen by 45.28%. And in the last five days, it has surged by 41.43%.
Elevation Oncology Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $5.83 on 04/03/24, and the lowest price during that time was $0.50, recorded on 10/10/24.
52-week price history of ELEV Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Elevation Oncology Inc’s current trading price is -85.60% away from its 52-week high, while its distance from the 52-week low is 67.88%. The stock’s price range for this period has been between $0.50 and $5.83. The Healthcare sector company’s shares saw a trading volume of about 8.24 million for the day, which was higher than the average daily volume of 0.81 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Elevation Oncology Inc (ELEV) has experienced a quarterly rise of 55.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 55.35M and boasts a workforce of 29 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6211, with a change in price of +0.0813. Similarly, Elevation Oncology Inc recorded 865,188 in trading volume during the last 100 days, posting a change of +10.72%.
ELEV’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ELEV stands at 0.45. Similarly, the long-term debt-to-equity ratio is also 0.45.
ELEV Stock Stochastic Average
As of today, the raw stochastic average of Elevation Oncology Inc over the last 50 days is at 76.77%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 75.40%. Further, the company’s Stochastic %K and %D values for the last 20 days were 46.37% and 26.84%, respectively.
